Paris-based HealthTech Lifeaz secures €13M to expand its connected defibrillator network across Europe. Discover how they are turning ordinary citizens into life-savers.
Democratizing Life-Saving: How Lifeaz is Scaling to Save 1,000 Lives by 2031
When a cardiac arrest occurs, every minute without intervention reduces the chance of survival by 10%. Despite this, most people don’t have access to a defibrillator at home, and many feel unprepared to use one. Lifeaz is solving both the access and the confidence gap.
By raising €13 million in a round supported by Mutuelles Impact, BNP Paribas, GO CAPITAL, and Mirova, Lifeaz is transitioning from a successful French startup to a pan-European HealthTech leader.
The Innovation: “Clark,” the Connected Life-Saver
Lifeaz’s flagship product, Clark, is the first defibrillator specifically designed for home use. Manufactured in Normandy, it addresses the two biggest hurdles in cardiac emergency response:
- Readiness: Through 4G connectivity and daily automated self-tests, Clark ensures it is always operational. No more worrying about dead batteries or expired pads.
- Confidence: The platform combines hardware with a comprehensive training app and video sessions, ensuring that whether you are in a restaurant, gym, or your living room, you feel prepared to act.
A Business Model Built for Scale
Lifeaz operates on a turnkey rental model. For a fixed fee, businesses and individuals get the device, remote maintenance, consumable replacements, and ongoing training. It’s a “safety-as-a-service” model that has already saved over 100 lives.
With this new capital, the goal is ambitious: save 1,000 lives within five years and grow from 25,000 to over 100,000 customers.
Scaling the HealthTech Frontier: The Fundreef Perspective
Lifeaz’s success is part of a massive 2025-2026 surge in cardiovascular HealthTech, following recent raises by players like FineHeart (€35M) and Ultromics (€48M). For founders in the medical device and safety space, this capital influx proves that “impact at scale” is a winning narrative for VCs.
If you are building a mission-driven hardware startup, our toolkit can help you navigate the complexities of a Lifeaz-style raise:
- Valuation Benchmarking: MedTech and HealthTech valuations in 2026 are heavily influenced by clinical data and social impact. Use our AI Company Valuation tool to see where you stand.
- The Regulatory Narrative: Moving from one country to a pan-European rollout requires a flawless strategy. Our AI Business Plan tool helps you structure your expansion and hiring roadmap (Lifeaz is adding 20 new hires this year alone).
- Investor Synergy: Looking for impact-focused funds like Mutuelles Impact or Mirova? Our Investor Database filters for the specific VCs who prioritize long-term human impact alongside financial returns.
- Closing the Round: Managing a cap table with big names like BNP Paribas requires a clear understanding of your rights. Use our AI Term Sheet Analysis to ensure your interests are protected as you scale.
Final Thoughts: The Minute-Away Vision
CEO Johann Kalchman envisions a future where a defibrillator is always less than one minute away. Lifeaz isn’t just selling hardware; they are building a network of prepared citizens.
Are you building a startup that saves lives? Let us help you find the capital to make it happen at Fundreef.com.
